Income Statement (TTM)
Cue Health Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23 | 87 | 220 | 439 | 618 | 733 | 683 | 529 | 483 | 329 | 251 | 199 | 71 | 56 |
| Change (%) | 278.34 | 153.24 | 99.56 | 40.84 | 18.59 | -6.78 | -22.55 | -8.64 | -31.99 | -23.66 | -20.76 | -64.34 | -20.74 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 43 | 74 | 121 | 209 | 319 | 397 | 484 | 479 | 501 | 470 | 390 | 357 | 266 | 227 |
| Change (%) | 69.39 | 64.48 | 72.84 | 52.72 | 24.44 | 21.66 | -0.94 | 4.69 | -6.17 | -17.01 | -8.66 | -25.50 | -14.66 | |
| % of Revenue | 189.21 | 84.71 | 55.02 | 47.65 | 51.67 | 54.22 | 70.76 | 90.51 | 103.71 | 143.08 | 155.55 | 179.30 | 374.58 | 403.29 |
| Gross Operating Profit | -20 | 13 | 99 | 230 | 299 | 336 | 200 | 50 | -18 | -142 | -139 | -158 | -195 | -171 |
| Change (%) | -164.84 | 645.03 | 132.25 | 30.03 | 12.34 | -40.47 | -74.86 | -135.73 | 689.27 | -1.56 | 13.11 | 23.48 | -12.45 | |
| % of Revenue | -89.21 | 15.29 | 44.98 | 52.35 | 48.33 | 45.78 | 29.24 | 9.49 | -3.71 | -43.08 | -55.55 | -79.30 | -274.58 | -303.29 |
| SG&A | 25 | 27 | 37 | 72 | 109 | 157 | 187 | 192 | 186 | 153 | 133 | 112 | 90 | 70 |
| Change (%) | 8.12 | 39.03 | 94.31 | 50.73 | 44.95 | 18.74 | 2.73 | -3.22 | -17.71 | -12.84 | -15.66 | -19.92 | -21.89 | |
| % of Revenue | 107.39 | 30.69 | 16.85 | 16.40 | 17.56 | 21.46 | 27.33 | 36.26 | 38.41 | 46.46 | 53.05 | 56.46 | 126.79 | 124.95 |
| R&D | ||||||||||||||
| Change (%) | ||||||||||||||
| % of Revenue | ||||||||||||||
| OpEx | 68 | 100 | 158 | 281 | 428 | 555 | 670 | 671 | 687 | 623 | 524 | 448 | 335 | 276 |
| Change (%) | 46.16 | 58.84 | 77.87 | 52.21 | 29.64 | 20.83 | 0.08 | 2.43 | -9.29 | -15.99 | -14.44 | -25.29 | -17.52 | |
| % of Revenue | 296.60 | 114.58 | 71.87 | 64.06 | 69.23 | 75.67 | 98.09 | 126.76 | 142.12 | 189.55 | 208.60 | 225.24 | 471.85 | 490.99 |
| Operating Income | -45 | -13 | 62 | 158 | 190 | 178 | 13 | -142 | -204 | -294 | -273 | -249 | -264 | -220 |
| Change (%) | -71.94 | -588.52 | 154.98 | 20.59 | -6.26 | -92.70 | -1,187.43 | 43.78 | 44.60 | -7.41 | -8.62 | 5.88 | -16.66 | |
| % of Revenue | -196.60 | -14.58 | 28.13 | 35.94 | 30.77 | 24.33 | 1.91 | -26.76 | -42.12 | -89.55 | -108.60 | -125.24 | -371.85 | -390.99 |
| Interest Expense | -0 | -1 | -10 | -10 | -10 | -9 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Change (%) | 116.84 | 1,077.56 | 3.16 | -0.44 | -4.93 | 37.23 | 26.20 | 33.78 | -3.86 | 10.70 | -6.21 | |||
| % of Revenue | -1.63 | -0.93 | -4.34 | -2.24 | -1.59 | -1.27 | -0.09 | -0.13 | -0.25 | -0.43 | -0.53 | -1.63 | -1.93 | |
| Net Income | -47 | -26 | 5 | 33 | 86 | 76 | -43 | -128 | -194 | -291 | -276 | -257 | -373 | -329 |
| Change (%) | -46.03 | -118.65 | 585.10 | 164.66 | -11.84 | -156.00 | 200.73 | 51.23 | 49.99 | -5.22 | -7.01 | 45.58 | -11.96 | |
| % of Revenue | -206.30 | -29.43 | 2.17 | 7.44 | 13.98 | 10.39 | -6.24 | -24.25 | -40.14 | -88.51 | -109.90 | -128.97 | -526.48 | -584.76 |
Source: Capital IQ
